The most common mutations were TP53, KRAS, IDH, BRAF, and PIK3CA. Isocitrate dehydrogenase mutations (IDH1/2) are common in intrahepatic cholangiocarcinoma (13%) [23,24]. Here, KRAS is linked to intrahepatic cholangiocarcinoma.